These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34301486)

  • 1. Effect of high-dose sulfamethoxazole/trimethoprim and glucocorticoid use on hyperkalemic event: A retrospective observational study.
    Hirai T; Yamaga R; Ishikawa Y; Hanada K; Iwamoto T; Itoh T
    J Infect Chemother; 2021 Nov; 27(11):1607-1613. PubMed ID: 34301486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
    Alappan R; Buller GK; Perazella MA
    Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R; Perazella MA; Buller GK
    Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-induced hyperkalemia in burn patients treated with intravenous or oral trimethoprim sulfamethoxazole for methicillin-resistant Staphylococcus aureus and other infections: nature or nurture?
    Ackerman BH; Patton ML; Guilday RE; Haith LR; Stair-Buchmann M; Reigart CL
    J Burn Care Res; 2013; 34(1):127-32. PubMed ID: 23292580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
    Yokoyama S; Nakagawa J; Aiuchi N; Seito T; Niioka T
    J Clin Pharm Ther; 2022 Sep; 47(9):1409-1417. PubMed ID: 35545234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim.
    Caulder CR; Kocherla CS; Qureshi ZP; Magagnoli J; Bookstaver PB
    Ann Pharmacother; 2020 Sep; 54(9):852-857. PubMed ID: 32106685
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim is a potassium-sparing diuretic like amiloride and causes hyperkalemia in high-risk patients.
    Perazella MA
    Am J Ther; 1997; 4(9-10):343-8. PubMed ID: 10423629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
    Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
    Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T; Gomes T; Juurlink DN; Loutfy MR; Glazier RH; Mamdani MM
    Arch Intern Med; 2010 Jun; 170(12):1045-9. PubMed ID: 20585070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: severe hyperkalemia in a geriatric patient receiving standard doses of trimethoprim-sulfamethoxazole.
    Perlmutter EP; Sweeney D; Herskovits G; Kleiner M
    Am J Med Sci; 1996 Feb; 311(2):84-5. PubMed ID: 8615380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy.
    Greenberg S; Reiser IW; Chou SY
    Am J Kidney Dis; 1993 Oct; 22(4):603-6. PubMed ID: 8213804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications.
    Gentry CA; Nguyen AT
    Ann Pharmacother; 2013 Dec; 47(12):1618-26. PubMed ID: 24259630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole and the risk of a hospital encounter with hyperkalemia: a matched population-based cohort study.
    Hwang YJ; Muanda FT; McArthur E; Weir MA; Sontrop JM; Lam NN; Garg AX
    Nephrol Dial Transplant; 2023 May; 38(6):1459-1468. PubMed ID: 36208171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
    Antoniou T; Gomes T; Mamdani MM; Yao Z; Hellings C; Garg AX; Weir MA; Juurlink DN
    BMJ; 2011 Sep; 343():d5228. PubMed ID: 21911446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkalemia and trimethoprim-sulfamethoxazole: a new problem emerges 25 years later.
    Perazella MA
    Conn Med; 1997 Aug; 61(8):451-8. PubMed ID: 9309892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
    Perazella MA; Mahnensmith RL
    Clin Nephrol; 1996 Sep; 46(3):187-92. PubMed ID: 8879854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
    Nguyen AT; Gentry CA; Furrh RZ
    Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemia and high-dose trimethoprim/sulfamethoxazole.
    Hsu I; Wordell CJ
    Ann Pharmacother; 1995 Apr; 29(4):427-9. PubMed ID: 7633023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population kinetic-pharmacodynamic analysis of serum potassium in patients receiving sulfamethoxazole/trimethoprim.
    Hirai T; Shiraishi C; Nakai S; Ushiro M; Hanada K; Iwamoto T
    Basic Clin Pharmacol Toxicol; 2022 Nov; 131(5):380-391. PubMed ID: 36000348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.
    Greenberg S; Reiser IW; Chou SY; Porush JG
    Ann Intern Med; 1993 Aug; 119(4):291-5. PubMed ID: 8328737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.